Shattuck Labs financials
$6.82+4.28%
Close Sep 30, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 |
|---|---|---|---|---|---|---|
| Revenue | $1.0M | $5.7M | $1.7M | $652.0K | $30.0M | $9.9M |
| Gross profit | $1.0M | $5.7M | $1.7M | $652.0K | $30.0M | $9.9M |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating income | -$51.5M | -$80.6M | -$92.0M | -$103.3M | -$45.3M | -$36.9M |
| Net income | -$48.8M | -$75.4M | -$87.3M | -$101.9M | -$45.0M | -$36.6M |
| Net margin | −4880.9% | −1318.1% | −5268.4% | −15635.7% | −149.8% | −368.5% |
| Diluted EPS | $-0.70 | $-1.49 | $-2.05 | $-2.41 | $-1.07 | $-2.36 |
| EBITDA | -$47.8M | -$76.7M | -$87.9M | -$100.0M | -$43.9M | -$36.3M |
| Operating cash flow | -$39.9M | -$60.5M | -$81.2M | -$94.5M | -$57.1M | -$33.7M |
| Free cash flow | -$40.0M | -$60.6M | -$81.6M | -$106.1M | -$65.0M | -$34.4M |
| Diluted shares | 69.6M | 50.8M | 42.6M | 42.4M | 42.0M | 15.5M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $54.2M | $57.4M | $125.6M | $47.4M | $92.3M | $157.9M |
| Short-term investments | $23.9M | $15.6M | $5.0M | $113.9M | $176.5M | $177.6M |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $91.0M | $91.0M | $159.6M | $205.3M | $298.6M | $349.0M |
| Total liabilities | $8.6M | $11.4M | $14.9M | $29.2M | $26.8M | $39.1M |
| Shareholders' equity | $82.4M | $79.6M | $144.7M | $176.2M | $271.8M | $309.9M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology